- Home
- AARD vs WSBF Comparison
AARD vs WSBF Comparison
Compare AARD & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AARD | WSBF |
|---|---|---|
| Founded | 2017 | 1921 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.1M | 336.0M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | AARD | WSBF |
|---|---|---|
| Price | $3.72 | $18.25 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $19.63 | N/A |
| AVG Volume (30 Days) | ★ 487.6K | 58.9K |
| Earning Date | 03-23-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 3.30% |
| EPS Growth | N/A | ★ 46.53 |
| EPS | N/A | ★ 1.48 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,107.17 | N/A |
| P/E Ratio | ★ N/A | $12.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.35 | $11.61 |
| 52 Week High | $17.94 | $18.88 |
Technical Indicators
Market Signals| Indicator | AARD | WSBF |
|---|---|---|
| Relative Strength Index (RSI) | 22.54 | 58.49 |
| Support Level | N/A | $16.90 |
| Resistance Level | $6.19 | $18.61 |
| Average True Range (ATR) | 0.38 | 0.39 |
| MACD | 0.14 | 0.05 |
| Stochastic Oscillator | 17.29 | 72.43 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The majority of its revenue comes from the Community Banking segment.